CLINICAL_TRIALS
trial_result
· 2021-08-31
Clinical Trial Update: A Study of LY3415244 in Participants With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 study of LY3415244 in advanced solid tumors was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Solid Tumor | Phase 1 | Status: TERMINATED | Results posted: 2021-08-31